Australia - Electronic Prescribing Industry Offer - Second Round

Description

The successful Tenderer will be required to complete the conformance testing of their software product (as applicable) in accordance with the process specified in the Agency document “Electronic Prescribing – Conformance Assessment Scheme” and applicable sections of the Agency document “Electronic Prescribing  Conformance Profile v3.0.
 
To achieve the “full” electronic prescribing functionality, software products will be required to:
Submit a project plan detailing how the Services will be undertaken;
•&nbspUndertake Healthcare Identifier (HI) conformance (CIS products ONLY);
•&nbspSuccessfully complete conformance testing of their software product(s);
•&nbspUpon successful completion of the Electronic Prescribing conformance process, as evidenced by a test report authored by an open Prescription Delivery Service provider (or the Agency, subject to written agreement by the Agency), submit a signed conformance declaration deed poll form to the Agency; and
•&nbspRelease the conformant software product to market as evidenced through beta testing.

Opportunity closing date

28 May 2021

Value of contract

to be confirmed